The different faces of echocardiographic left ventricular hypertrophy: Clues to the etiology

Journal of the American Society of Echocardiography

Volumn 23, Issue 8, 2010, Pages 793-801

  Weidemann, Frank ^a   Niemann, Markus ^a   Ertl, Georg ^a   Störk, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Echocardiography; Hypertrophy; Typical features

Indexed keywords

ATHLETE; CLINICAL PRACTICE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FABRY DISEASE; FRIEDREICH ATAXIA; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; REVIEW;

EID: 77956883741     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.05.020     Document Type: Review

References (63)

1. P. Elliott, and W.J. McKenna Hypertrophic cardiomyopathy Lancet 363 2004 1881 1891
2. B.M. Pluim, A.H. Zwinderman, A. van der Laarse, and E.E. van der Wall The athlete's heart. A meta-analysis of cardiac structure and function Circulation 101 2000 336 344
3. T.P. Huston, J.C. Puffer, and W.M. Rodney The athletic heart syndrome N Engl J Med 313 1985 24 32
4. B.J. Maron, and D.P. Zipes Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations J Am Coll Cardiol 45 2005 1318 1321
5. A. Pelliccia, R. Fagard, H.H. Bjornstad, A. Anastassakis, E. Arbustini, D. Assanelli, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 2005 1422 1445
6. B.J. Maron Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening Br J Sports Med 43 2009 649 656
7. P. Palka, A. Lange, A.D. Fleming, J.E. Donnelly, D.P. Dutka, I.R. Starkey, et al. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension J Am Coll Cardiol 30 1997 760 768
8. D. Vinereanu, N. Florescu, N. Sculthorpe, A.C. Tweddel, M.R. Stephens, and A.G. Fraser Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes Am J Cardiol 88 2001 53 58
9. M.B. Codd, D.D. Sugrue, B.J. Gersh, and L.J. Melton III Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984 Circulation 80 1989 564 572
10. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
11. H. Schirmer, P. Lunde, and K. Rasmussen Prevalence of left ventricular hypertrophy in a general population; the Tromso Study Eur Heart J 20 1999 429 438
12. P.M. Elliott, J.R. Gimeno Blanes, N.G. Mahon, J.D. Poloniecki, and W.J. McKenna Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424
13. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
14. M.S. Maron, B.J. Maron, C. Harrigan, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
15. H.G. Klues, A. Schiffers, and B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1995 1699 1708
16. K. Okeie, M. Shimizu, H. Yoshio, H. Ino, M. Yamaguchi, T. Matsuyama, T. Yasuda, J. Taki, and H. Mabuchi Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 36 2000 856 863
17. T.S. Kato, A. Noda, H. Izawa, A. Yamada, K. Obata, K. Nagata, et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography Circulation 110 2004 3808 3814
18. F. Weidemann, P. Jung, C. Hoyer, J. Broscheit, W. Voelker, G. Ertl, et al. Assessment of the contractile reserve in patients with intermediate coronary lesions: a strain rate imaging study validated by invasive myocardial fractional flow reserve Eur Heart J 28 2007 1425 1432
19. F. Weidemann, L. Mertens, M. Gewillig, and G.R. Sutherland Quantitation of localized abnormal deformation in asymmetric nonobstructive hypertrophic cardiomyopathy: a velocity, strain rate, and strain Doppler myocardial imaging study Pediatr Cardiol 22 2001 534 537
20. F. Weidemann, M. Niemann, S. Herrmann, M. Kung, S. Stork, C. Waller, et al. A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium Eur Heart J 28 2007 3020 3026
21. P.H. Pak, L. Maughan, K.L. Baughman, and D.A. Kass Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy Circulation 94 1996 52 60
22. B. Baker, B. O'Kelly, J.P. Szalai, M. Katic, D. McKessock, R. Ogilvie, et al. Determinants of left ventricular mass in early hypertension Am J Hypertens 11 1998 1248 1251
23. A. Celentano, F.P. Mancini, M. Crivaro, V. Palmieri, L.A. Ferrara, V. De Stefano, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension Am J Cardiol 83 1999 1196 1200
24. M. Buchi, O.M. Hess, T. Murakami, and H.P. Krayenbuehl Left ventricular wall stress distribution in chronic pressure and volume overload: effect of normal and depressed contractility on regional stress-velocity relations Basic Res Cardiol 85 1990 367 383
25. A. Baltabaeva, M. Marciniak, B. Bijnens, J. Moggridge, F.J. He, T.F. Antonios, et al. Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension Eur J Echocardiogr 9 2008 501 508
26. R. Plaksej, W. Kosmala, S. Frantz, S. Herrmann, M. Niemann, S. Stork, et al. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure J Hypertens 27 2009 2483 2491
27. M. Slama, D. Susic, J. Varagic, and E.D. Frohlich Diastolic dysfunction in hypertension Curr Opin Cardiol 17 2002 368 373
28. J.A. Sallach, and A.L. Klein Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis Curr Opin Cardiol 19 2004 464 471
29. R.A. Kyle, and P.R. Greipp Amyloidosis (AL). Clinical and laboratory features in 229 cases Mayo Clin Proc 58 1983 665 683
30. L. Cueto-Garcia, G.S. Reeder, R.A. Kyle, D.L. Wood, J.B. Seward, J. Naessens, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival J Am Coll Cardiol 6 1985 737 743
31. D. Bellavia, P.A. Pellikka, G.B. Al-Zahrani, T.P. Abraham, A. Dispenzieri, C. Miyazaki, et al. Independent predictors of survival in primary systemic (AL) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study J Am Soc Echocardiogr 23 2010 643 652
32. G.B. Al-Zahrani, D. Bellavia, P.A. Pellikka, A. Dispenzieri, S.R. Hayman, J.K. Oh, et al. Doppler myocardial imaging compared to standard two-dimensional and Doppler echocardiography for assessment of diastolic function in patients with systemic amyloidosis J Am Soc Echocardiogr 22 2009 290 298
33. D. Bellavia, T.P. Abraham, P.A. Pellikka, G.B. Al-Zahrani, A. Dispenzieri, J.K. Oh, et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography J Am Soc Echocardiogr 20 2007 1194 1202
34. J. Koyama, and R.H. Falk Prognostic significance of strain Doppler imaging in light-chain amyloidosis JACC Cardiovasc Imaging 3 2010 333 342
35. J.L. Bradley, J.C. Blake, S. Chamberlain, P.K. Thomas, J.M. Cooper, and A.H. Schapira Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia Hum Mol Genet 9 2000 275 282
36. R. Hewer The heart in Friedreich's ataxia Br Heart J 31 1969 5 14
37. J.S. Child, J.K. Perloff, P.M. Bach, A.D. Wolfe, S. Perlman, and R.A. Kark Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients J Am Coll Cardiol 7 1986 1370 1378
38. D.P. Dutka, J.E. Donnelly, P. Palka, A. Lange, D.J. Nunez, and P. Nihoyannopoulos Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients Circulation 102 2000 1276 1282
39. F. Casazza, F. Ferrari, U. Piccone, S. Maggiolini, A. Capozi, and M. Morpurgo Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study [article in Italian] Cardiologia 35 1990 423 431
40. P. Ferres-Sanchez, M. Subirana-Domenech, and M. Torner-Soler Chest pain during exercise as first manifestation of Friedreich's ataxia Br Heart J 74 1995 464 467
41. A. Giunta, S. Maione, R. Biagini, A. Filla, G. De Michele, and G. Campanella Noninvasive assessment of systolic and diastolic function in 50 patients with Friedreich's ataxia Cardiology 75 1988 321 327
42. S.H. Poulsen, P. Sogaard, J.E. Nielsen-Kudsk, and H. Egeblad Dilated cardiomyopathy in Friedreich's ataxia: 2D echo and tissue-Doppler analysis of left ventricular and atrial function Eur J Echocardiogr 4 2003 331 333
43. L. Monserrat, J.R. Gimeno-Blanes, F. Marin, M. Hermida-Prieto, A. Garcia-Honrubia, I. Perez, et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy J Am Coll Cardiol 50 2007 2399 2403
44. S. Nakao, T. Takenaka, M. Maeda, C. Kodama, A. Tanaka, M. Tahara, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy N Engl J Med 333 1995 288 293
45. A. Mehta, R. Ricci, U. Widmer, F. Dehout, A. Garcia de Lorenzo, C. Kampmann, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey Eur J Clin Invest 34 2004 236 242
46. F. Weidemann, F. Breunig, M. Beer, J. Sandstede, S. Stork, W. Voelker, et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease Eur Heart J 26 2005 1221 1227
47. F. Weidemann, J.M. Strotmann, F. Breunig, M. Niemann, R. Maag, R. Baron, et al. Misleading terms in Anderson-Fabry disease Eur J Clin Invest 38 2008 191 196
48. F. Weidemann, C. Wanner, and F. Breunig Nomen est omen. Fabry disease Eur J Echocardiogr 9 2008 831 832
49. B.A. Austin, D.H. Kwon, N.G. Smedira, M. Thamilarasan, H.M. Lever, and M.Y. Desai Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy J Am Soc Echocardiogr 22 2009 e105 e106
50. F. Weidemann, M. Niemann, F. Breunig, S. Herrmann, M. Beer, S. Stork, et al. Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment Circulation 119 2009 524 529
51. J.C. Moon, B. Sachdev, A.G. Elkington, W.J. McKenna, A. Mehta, D.J. Pennell, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium Eur Heart J 24 2003 2151 2155
52. R. Jenni, E.N. Oechslin, and B. van der Loo Isolated ventricular non-compaction of the myocardium in adults Heart 93 2007 11 15
53. E.N. Oechslin, C.H. Attenhofer Jost, J.R. Rojas, P.A. Kaufmann, and R. Jenni Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis J Am Coll Cardiol 36 2000 493 500
54. B.W. Eidem Noninvasive evaluation of left ventricular noncompaction: what's new in 2009? Pediatr Cardiol 30 2009 682 689
55. F.S. Buck, M.N. Koss, A.E. Sherrod, A. Wu, and M. Takahashi Ethnic distribution of amyloidosis: an autopsy study Mod Pathol 2 1989 372 377
56. S. Morner, U. Hellman, O.B. Suhr, E. Kazzam, and A. Waldenstrom Amyloid heart disease mimicking hypertrophic cardiomyopathy J Intern Med 258 2005 225 230
57. B. Sachdev, T. Takenaka, H. Teraguchi, C. Tei, P. Lee, W.J. McKenna, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy Circulation 105 2002 1407 1411
58. N. Espinola-Zavaleta, M.E. Soto, L.M. Castellanos, S. Jativa-Chavez, and C. Keirns Non-compacted cardiomyopathy: clinical-echocardiographic study Cardiovasc Ultrasound 4 2006 35
59. R.B. Devereux, K. Wachtell, E. Gerdts, K. Boman, M.S. Nieminen, V. Papademetriou, et al. Prognostic significance of left ventricular mass change during treatment of hypertension JAMA 292 2004 2350 2356
60. F. Weidemann, F. Breunig, M. Beer, J. Sandstede, O. Turschner, W. Voelker, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study Circulation 108 2003 1299 1301
61. G. Buyse, L. Mertens, G. Di Salvo, I. Matthijs, F. Weidemann, B. Eyskens, et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring Neurology 60 2003 1679 1681
62. Z.B. Popovic, D.H. Kwon, M. Mishra, A. Buakhamsri, N.L. Greenberg, M. Thamilarasan, et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging J Am Soc Echocardiogr 21 2008 1299 1305
63. W. Kosmala, R. Plaksej, J.M. Strotmann, C. Weigel, S. Herrmann, M. Niemann, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study J Am Soc Echocardiogr 21 2008 1309 1317